53 related articles for article (PubMed ID: 22938452)
1. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.
Khoury T; Chandrasekhar R; Wilding G; Tan D; Cheney RT
Int J Exp Pathol; 2011 Apr; 92(2):87-96. PubMed ID: 21044186
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effectiveness of chemotherapy for thymic epithelial tumors using the CD-DST method.
Yu L; Zhang BX; Du X; Yu Z; Yang XG; Jiang YX
Thorac Cancer; 2020 May; 11(5):1160-1169. PubMed ID: 32196982
[TBL] [Abstract][Full Text] [Related]
3. Juan Rosai as master of our comprehensive understanding of thymus and thymoma.
Marino M; Marx A; Anemona L; Lauriola L; Ströbel P; Müller-Hermelink HK
Pathologica; 2021 Oct; 113(5):360-370. PubMed ID: 34837094
[TBL] [Abstract][Full Text] [Related]
4. WHO histological classification and tumor size are predictors of the locally aggressive behavior of thymic epithelial tumors.
Gao J; Ao Y; Wang S; Chen Z; Zhang Y; Ding J; Jiang J
Lung Cancer; 2024 Jan; 187():107446. PubMed ID: 38113654
[TBL] [Abstract][Full Text] [Related]
5. ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors.
Chiappetta M; Lococo F; Sassorossi C; Aigner C; Ploenes T; Van Raemdonck D; Vanluyten C; Van Schil P; Agrafiotis A; Guerrera F; Lyberis P; Casiraghi M; Spiaggiari L; Zisis C; Magou C; Moser B; Bauer J; Thomas PA; Brioude G; Passani S; Zsanto Z; Sperduti I; Margaritora S
Ann Surg Oncol; 2024 Jul; 31(7):4327-4328. PubMed ID: 38643340
[No Abstract] [Full Text] [Related]
6. ASO Visual Abstract: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database.
Chiappetta M; Lococo F; Sassorossi C; Aigner C; Ploenes T; Van Raemdonck D; Vanluyten C; Van Schil P; Agrafiotis A; Guerrera F; Lyberis P; Casiraghi M; Spiaggiari L; Zisis C; Magou C; Moser B; Bauer J; Thomas PA; Brioude G; Passani S; Zsanto Z; Sperduti I; Margaritora S
Ann Surg Oncol; 2024 Jul; 31(7):4337-4338. PubMed ID: 38714625
[No Abstract] [Full Text] [Related]
7. CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets.
Kashima J; Hishima T; Okuma Y; Horio H; Ogawa M; Hayashi Y; Horiguchi SI; Motoi T; Ushiku T; Fukayama M
Front Oncol; 2021; 11():808396. PubMed ID: 35145909
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma.
Jeong JH; Pyo JS; Kim NY; Kang DW
Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32640732
[No Abstract] [Full Text] [Related]
9. CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.
Huang R; Wu D; Yuan Y; Li X; Holm R; Trope CG; Nesland JM; Suo Z
PLoS One; 2014; 9(11):e112209. PubMed ID: 25380303
[TBL] [Abstract][Full Text] [Related]
10. [Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France].
Hadoux J; Girard N; Besse B
Bull Cancer; 2012 Nov; 99(11):1045-55. PubMed ID: 23131309
[TBL] [Abstract][Full Text] [Related]
11. Staging of thymic epithelial neoplasms: thymoma and thymic carcinoma.
Weissferdt A; Moran CA
Pathol Res Pract; 2015 Jan; 211(1):2-11. PubMed ID: 25441660
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and clinical significance of KIT(CD117) expression in thymic epithelial tumors in China.
Song N; Chen G; Zhang P; Liu M; He WX; Jiang GN
Asian Pac J Cancer Prev; 2012; 13(6):2745-8. PubMed ID: 22938452
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
[TBL] [Abstract][Full Text] [Related]
15. Expression and mutational status of c-kit in thymic epithelial tumors.
Petrini I; Zucali PA; Lee HS; Pineda MA; Meltzer PS; Walter-Rodriguez B; Roncalli M; Santoro A; Wang Y; Giaccone G
J Thorac Oncol; 2010 Sep; 5(9):1447-53. PubMed ID: 20651610
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
